421 related articles for article (PubMed ID: 7902202)
1. Overexpression of c-erbB-2 protein in gastric cancer. Its correlation with long-term survival of patients.
Uchino S; Tsuda H; Maruyama K; Kinoshita T; Sasako M; Saito T; Kobayashi M; Hirohashi S
Cancer; 1993 Dec; 72(11):3179-84. PubMed ID: 7902202
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of the overexpression of c-erbB-2 protein in adenocarcinoma of the uterine cervix.
Kihana T; Tsuda H; Teshima S; Nomoto K; Tsugane S; Sonoda T; Matsuura S; Hirohashi S
Cancer; 1994 Jan; 73(1):148-53. PubMed ID: 7506116
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of DNA ploidy and c-erbB-2 oncoprotein overexpression in adenocarcinoma of Barrett's esophagus.
Nakamura T; Nekarda H; Hoelscher AH; Bollschweiler E; Harbeck N; Becker K; Siewert JR; Harbec N [corrected to Harbeck N]
Cancer; 1994 Apr; 73(7):1785-94. PubMed ID: 7907940
[TBL] [Abstract][Full Text] [Related]
4. Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer.
Mizutani T; Onda M; Tokunaga A; Yamanaka N; Sugisaki Y
Cancer; 1993 Oct; 72(7):2083-8. PubMed ID: 8397058
[TBL] [Abstract][Full Text] [Related]
5. Clinicopathological significance of c-erbB-2 protein expression in human gastric carcinoma.
Tateishi M; Toda T; Minamisono Y; Nagasaki S
J Surg Oncol; 1992 Apr; 49(4):209-12. PubMed ID: 1348293
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of beta-catenin and c-erbB-2 in early gastric cancer.
Ougolkov A; Mai M; Takahashi Y; Omote K; Bilim V; Shimizu A; Minamoto T
J Exp Clin Cancer Res; 2000 Sep; 19(3):349-55. PubMed ID: 11144528
[TBL] [Abstract][Full Text] [Related]
7. Frequent microsatellite instability in papillary and solid-type, poorly differentiated adenocarcinomas of the stomach.
Arai T; Sakurai U; Sawabe M; Honma N; Aida J; Ushio Y; Kanazawa N; Kuroiwa K; Takubo K
Gastric Cancer; 2013 Oct; 16(4):505-12. PubMed ID: 23274922
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
9. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of E-cadherin hypermethylation to tumorigenesis and development of gastric cancer].
Liu WT; Jiao HL; Yang YL; Wang D; Zhang WM
Ai Zheng; 2007 Nov; 26(11):1199-203. PubMed ID: 17991318
[TBL] [Abstract][Full Text] [Related]
11. [Expression and significance of CD147 and E-cadherin in human gastric carcinoma].
Wang LL; Yao GY; Zhang BY; Zhang XM; Zhao M
Zhonghua Zhong Liu Za Zhi; 2009 Jul; 31(7):515-9. PubMed ID: 19950699
[TBL] [Abstract][Full Text] [Related]
12. Comparison of c-erbB-2 oncoprotein expression in tissue and serum of patients with stomach cancer.
Chariyalertsak S; Sugano K; Ohkura H; Mori Y
Tumour Biol; 1994; 15(5):294-303. PubMed ID: 7991990
[TBL] [Abstract][Full Text] [Related]
13. Mixed-histologic-type submucosal invasive gastric cancer as a risk factor for lymph node metastasis: feasibility of endoscopic submucosal dissection.
Hanaoka N; Tanabe S; Mikami T; Okayasu I; Saigenji K
Endoscopy; 2009 May; 41(5):427-32. PubMed ID: 19418397
[TBL] [Abstract][Full Text] [Related]
14. [Expression of osteopontin mRNA and OCT2 mRNA in human gastric carcinoma by tissue microarray and its significance].
Zhang QY; Yao GY; Fu YP; Zhao ZS
Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):42-3. PubMed ID: 16608649
[No Abstract] [Full Text] [Related]
15. Correlation of c-erbB-2 with invasion and metastasis in human gastric cancer.
Mizutani T; Onda M; Tokunaga A; Fujita I; Okuda T; Iida S; Kiyama T; Nishi K; Matsukura N; Yamashita K
Gastroenterol Jpn; 1992 Jun; 27(3):424. PubMed ID: 1352509
[No Abstract] [Full Text] [Related]
16. Overexpression of YAP1 is correlated with progression, metastasis and poor prognosis in patients with gastric carcinoma.
Hu X; Xin Y; Xiao Y; Zhao J
Pathol Oncol Res; 2014 Oct; 20(4):805-11. PubMed ID: 24643316
[TBL] [Abstract][Full Text] [Related]
17. ADAM 10 is associated with gastric cancer progression and prognosis of patients.
Wang YY; Ye ZY; Li L; Zhao ZS; Shao QS; Tao HQ
J Surg Oncol; 2011 Feb; 103(2):116-23. PubMed ID: 21259244
[TBL] [Abstract][Full Text] [Related]
18. Relationship of p53 and c-erbB-2 expression to histopathological features, Helicobacter pylori infection and prognosis in gastric cancer.
Shun CT; Wu MS; Lin JT; Chen SY; Wang HP; Lee WJ; Wang TH; Chuang SM
Hepatogastroenterology; 1997; 44(14):604-9. PubMed ID: 9164544
[TBL] [Abstract][Full Text] [Related]
19. Signet ring cell type and other histologic types: differing clinical course and prognosis in T1 gastric cancer.
Kim BS; Oh ST; Yook JH; Kim BS
Surgery; 2014 Jun; 155(6):1030-5. PubMed ID: 24792508
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.
Yonemura Y; Ninomiya I; Yamaguchi A; Fushida S; Kimura H; Ohoyama S; Miyazaki I; Endou Y; Tanaka M; Sasaki T
Cancer Res; 1991 Feb; 51(3):1034-8. PubMed ID: 1670998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
